Germ-Line Mutations in Blood and Saliva Samples From Patients With Cancer (NCT02280161)
An Investigation of the Role of Germ-Line Mutations in Cancer Predisposition, Tumor Biology, and Response to Treatment
🩺 Plain-English Summary (8th-Grade Level)
This research trial studies germ-line mutations in blood and saliva samples from patients with cancer. Studying samples of blood and saliva from patients with cancer in the laboratory may help doctors learn more about how inherited genetic mutations can affect cancer predisposition (an inherited increase in the risk of developing cancer), their impact on treatment response, and their role in cancer development.
Who can join: Review the eligibility criteria below.
Location: Jonsson Comprehensive Cancer Center — Los Angeles, California
Age range: 18 Years
🧪 Interventions in This Study
- cytology specimen collection procedure (OTHER)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Jonsson Comprehensive Cancer Center — Los Angeles, California
📞 Contact the Study Coordinator
Phone: (310) 825-9775
Email: jweidhaas@mednet.ucla.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Malignant Neoplasm
- Molecular Profiling in Tissue Samples From Patients With Cancer Who Are Exceptional Responders to Treatment — Duarte, California
- Reproductive Health Program in Patients With Cancer — Jonesboro, Arkansas
- rTMS in Improving Neuropathy in Patients With Stage I-IV Cancer Who Have Received Oxaliplatin Chemotherapy — Houston, Texas
- Use of a Pre-Surgical Toolkit in Improving Surgical Care and Outcomes in Older Participants With Cancer — Newark, Delaware
- Web-Based Family Outreach Program for Cancer Prevention in High-Risk Families — Houston, Texas
- Gene and Vaccine Therapy in Treating Patients With Advanced Malignancies — Los Angeles, California
Explore by condition: All Malignant Neoplasm clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.